High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality - The CAVASIC Study

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 711-717

  Pohlhammer, Johannes ^a   Kronenberg, Florian ^a   Rantner, Barbara ^a   Stadler, Marietta ^b,c   Peric, Slobodan ^b   Hammerer Lercher, Angelika ^d   Klein Weigel, Peter ^e   Fraedrich, Gustav ^a   Kollerits, Barbara ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b HIETZING HOSPITAL   (Austria)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

Cardiovascular disease; High sensitivity cardiac troponin T; Mortality; NT proBNP; Peripheral arterial disease

Indexed keywords

TROPONIN T;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASES; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

EID: 84910070433     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.097     Document Type: Article

References (35)

1. Criqui M.H., Denenberg J.O., Langer R.D., Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc. Med. 1997, 2(3):221-226.
2. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G. Inter-society consensus for the management of peripheral arterial disease (TASC II). J.Vasc. Surg. 2007, 45(Suppl.S):S5-S67.
3. Diehm C., Allenberg J.R., Pittrow D., Mahn M., Tepohl G., Haberl R.L., et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009, 120(21):2053-2061.
4. Weitz J.I., Byrne J., Clagett G.P., Farkouh M.E., Porter J.M., Sackett D.L., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996, 94(11):3026-3049.
5. Aronow W.S. Management of peripheral arterial disease of the lower extremities in elderly patients. J.Gerontol. A Biol. Sci. Med. Sci. 2004, 59(2):172-177.
6. Mueller M., Vafaie M., Biener M., Giannitsis E., Katus H.A. Cardiac troponin T: from diagnosis of myocardial infarction to cardiovascular risk prediction. Circ. J. 2013, 77(7):1653-1661.
7. Latini R., Masson S., Anand I.S., Missov E., Carlson M., Vago T., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116(11):1242-1249.
8. Iversen K., Kober L., Gotze J.P., Dalsgaard M., Nielsen H., Boesgaard S., et al. Troponin T is a strong marker of mortality in hospitalized patients. Int. J. Cardiol. 2013, 168(2):818-824.
9. Mueller M., Biener M., Vafaie M., Blankenberg S., White H.D., Katus H.A., Giannitsis E. Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome. Int. J. Cardiol. 2014, 174(3):524-529.
10. Mantzouris T., Gauer R., Mackler L. Clinical inquiry: elevated troponin but no CVD: what's the prognosis?. J.Fam. Pract. 2013, 62(10):585-598.
11. de Lemos J.A., Drazner M.H., Omland T., Ayers C.R., Khera A., Rohatgi A., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304(22):2503-2512.
12. Masson S., Anand I., Favero C., Barlera S., Vago T., Bertocchi F., et al. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Circulation 2012, 125(2):280-288.
13. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 2011, 123(13):1367-1376.
14. Giannitsis E., Spanuth E., Horsch A., Kleber M.E., Koch W., Grammer T.B., et al. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin. Chem. Lab. Med. 2013, 51(10):2019-2028.
15. White H.D., Thygesen K., Alpert J.S., Jaffe A.S. Clinical implications of the third universal definition of myocardial infarction. Heart 2014, 100(5):424-432.
16. Wallace T.W., Abdullah S.M., Drazner M.H., Das S.R., Khera A., McGuire D.K., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006, 113(16):1958-1965.
17. Everett B.M., Cook N.R., Magnone M.C., Bobadilla M., Kim E., Rifai N., et al. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011, 123(24):2811-2818.
18. DeFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., Seliger S.L. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304(22):2494-2502.
19. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. Asensitive cardiac troponin T assay in stable coronary artery disease. N.Engl. J. Med. 2009, 361(26):2538-2547.
20. Wang A.Y., Lai K.N. Use of cardiac biomarkers in end-stage renal disease. J.Am. Soc. Nephrol. 2008, 19(9):1643-1652.
21. Daniels L.B., Laughlin G.A., Clopton P., Maisel A.S., Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J.Am. Coll. Cardiol. 2008, 52(6):450-459.
22. Eggers K.M., Al-Shakarchi J., Berglund L., Lindahl B., Siegbahn A., Wallentin L., Zethelius B. High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. Am. Heart J. 2013, 166(3):541-548.
23. Yu B., Barbalic M., Brautbar A., Nambi V., Hoogeveen R.C., Tang W., et al. Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies. Circ. Cardiovasc. Genet. 2013, 6(1):82-88.
24. White H.D. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?. J.Am. Coll. Cardiol. 2011, 57(24):2406-2408.
25. Montagnana M., Lippi G., Fava C., Minuz P., Santonastaso C.L., Arosio E., Guidi G.C. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease. Clin. Chem. Lab. Med. 2006, 44(2):207-212.
26. Rittoo D., Stahnke M., Lindesay C., Grocott E., Hickey N., Downing R. Prognostic significance of raised cardiac troponin T in patients presenting with acute limb ischaemia. Eur. J. Vasc. Endovasc. Surg. 2006, 32(5):500-503.
27. Linnemann B., Sutter T., Sixt S., Rastan A., Schwarzwaelder U., Noory E., et al. Elevated cardiac troponin T contributes to prediction of worse in-hospital outcomes after endovascular therapy for acute limb ischemia. J.Vasc. Surg. 2012, 55(3):721-729.
28. Linnemann B., Sutter T., Herrmann E., Sixt S., Rastan A., Schwarzwaelder U., et al. Elevated cardiac troponin t is associated with higher mortality and amputation rates in patients with peripheral arterial disease. J.Am. Coll. Cardiol. 2014, 63(15):1529-1538.
29. Rantner B., Kollerits B., Anderwald-Stadler M., Klein-Weigel P., Gruber I., Gehringer A., et al. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study. Clin. Chem. 2008, 54(5):851-857.
30. Kollerits B., Sturm G., Lamina C., Hammerer-Lercher A., Rantner B., Stadler M., et al. Comparison and evaluation of cardiac biomarkers in patients with intermittent claudication: results from the CAVASIC study. Clin. Chem. 2013, 59(4):692-702.
31. Falkensammer J., Gasteiger S., Stojakovic T., Stuhlinger M., Scharnagl H., Frech A., et al. Elevated baseline hs-cTnT levels predict exercise-induced myocardial ischemia in patients with peripheral arterial disease. Clin. Chim. Acta 2012, 413(19-20):1678-1682.
32. Twerenbold R., Jaffe A., Reichlin T., Reiter M., Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges?. Eur. Heart J. 2012, 33(5):579-586.
33. de Lemos J.A., Kumbhani D.J. Lessons from the heart: troponin elevations in patients with established peripheral artery disease. J.Am. Coll. Cardiol. 2014, 63(15):1539-1541.
34. Mueller T., Dieplinger B., Poelz W., Endler G., Wagner O.F., Haltmayer M. Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz peripheral arterial disease study. Clin. Chem. 2009, 55(1):68-77.
35. Bonaca M., Scirica B., Sabatine M., Dalby A., Spinar J., Murphy S.A., et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J.Am. Coll. Cardiol. 2010, 55(19):2118-2124.